Marsh Rodney, Cole Michael H, Dissanayaka Nadeeka N W, Au Tiffany R, Clewett Sandra, O'Sullivan John D, Silburn Peter A
School of Medicine, University of Queensland, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Brisbane, Australia.
Mental Health Service, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Brisbane, Australia.
Parkinsons Dis. 2019 Jul 24;2019:2478980. doi: 10.1155/2019/2478980. eCollection 2019.
The optimal prescription of cueing for the treatment of freezing of gait (FoG) in Parkinson's disease (PD) is currently a difficult problem for clinicians due to the heterogeneity of cueing modalities, devices, and the limited comparative trial evidence. There has been a rise in the development of motion-sensitive, wearable cueing devices for the treatment of FoG in PD. These devices generally produce cues after signature gait or electroencephalographic antecedents of FoG episodes are detected (phasic cues). It is not known whether these devices offer benefit over simple (tonic) cueing devices.
We assembled 20 participants with PD and FoG and familiarized them with a belt-worn, laser-light cueing device (Agilitas™). The device was designed with 2 cueing modalities-gait-dependent or "phasic" cueing and gait-independent or "tonic" cueing. Participants used the device sequentially in the off, phasic, or tonic modes, across 2 tasks-a 2-minute walk and an obstacle course.
A significant improvement in mean distance walked during the 2-minute walk test was observed for the tonic mode (127.3 m) compared with the off (111.4 m) and phasic (116.1 m) conditions. In contrast, there was a nonsignificant trend toward improvement in FoG frequency, duration, and course time when the device was switched from off to tonic and to phasic modes for the obstacle course.
Parkinson's disease patients with FoG demonstrated an improvement in distance walked during the two-minute walk test when a cueing device was switched from off to phasic and to tonic modes of operation. However, this benefit was lost when patients negotiated an obstacle course.
由于提示方式、设备的异质性以及有限的对比试验证据,目前为帕金森病(PD)患者的冻结步态(FoG)制定最佳提示方案对临床医生来说是个难题。用于治疗PD患者FoG的运动敏感型可穿戴提示设备的研发有所增加。这些设备通常在检测到FoG发作的标志性步态或脑电图先兆后产生提示(相位性提示)。尚不清楚这些设备是否比简单(持续性)提示设备更具优势。
我们招募了20名患有PD和FoG的参与者,并让他们熟悉一种佩戴在腰部的激光提示设备(Agilitas™)。该设备设计了两种提示方式——步态相关或“相位性”提示以及步态无关或“持续性”提示。参与者在两项任务(2分钟步行和障碍课程)中依次以关闭、相位性或持续性模式使用该设备。
在2分钟步行测试中,与关闭状态(111.4米)和相位性状态(116.1米)相比,持续性模式(127.3米)下观察到平均步行距离有显著改善。相比之下,在障碍课程中,当设备从关闭模式切换到持续性模式和相位性模式时,FoG频率、持续时间和课程时间虽有改善趋势,但不显著。
患有FoG的PD患者在提示设备从关闭模式切换到相位性模式和持续性模式进行2分钟步行测试时,步行距离有所改善。然而,当患者通过障碍课程时,这种益处消失了。